NEW YORK, United States, Aug. 08, 2022 (GLOBE NEWSWIRE) -- According toFacts and Factors has published a new research report titled “Blood Plasma Fractionation Market Size, Share, Growth Analysis ...
Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Plasma Fractionation Market Industry Trends and Global Forecasts to 2035, by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
MELAKA: Every bag of blood donated in the historic city will now help produce critical medicines for patients across the country under the National Fractionation Programme. State health, human ...
The NHS has resumed using UK-sourced blood plasma products for the first time since a 1988 ban. The move is part of efforts to reduce reliance on imported plasma-derived medicines. The Department of ...
Blood plasma contains more than 120 valuable proteins and is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of ...
There has been a monumental policy shift in paying plasma donors in Canada. In September, Canadian Blood Services (CBS) made a 15-year deal with Spanish health-care giant Grifols for blood plasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results